These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 30569110

  • 21. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
    Lu D, Sun L, Li Z, Mu Z.
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
    [Abstract] [Full Text] [Related]

  • 22. Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma.
    Shah PA, Sambandam V, Fernandez AM, Zhao H, Mazumdar T, Shen L, Wang Q, Ahmed KM, Ghosh S, Frederick MJ, Wang J, Johnson FM.
    Cancer Res; 2022 Dec 02; 82(23):4444-4456. PubMed ID: 36169922
    [Abstract] [Full Text] [Related]

  • 23. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
    Pan ST, Qin Y, Zhou ZW, He ZX, Zhang X, Yang T, Yang YX, Wang D, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Dec 02; 9():1601-26. PubMed ID: 25834400
    [Abstract] [Full Text] [Related]

  • 24. DKK3/CKAP4 axis is associated with advanced stage and poorer prognosis in oral cancer.
    Katase N, Kudo K, Ogawa K, Sakamoto Y, Nishimatsu SI, Yamauchi A, Fujita S.
    Oral Dis; 2023 Nov 02; 29(8):3193-3204. PubMed ID: 35708905
    [Abstract] [Full Text] [Related]

  • 25. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
    Gen Y, Yasui K, Nishikawa T, Yoshikawa T.
    Cancer Sci; 2013 Jul 02; 104(7):810-6. PubMed ID: 23510069
    [Abstract] [Full Text] [Related]

  • 26. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
    Mohan S, Vander Broek R, Shah S, Eytan DF, Pierce ML, Carlson SG, Coupar JF, Zhang J, Cheng H, Chen Z, Van Waes C.
    Clin Cancer Res; 2015 Sep 01; 21(17):3946-56. PubMed ID: 25977343
    [Abstract] [Full Text] [Related]

  • 27. Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma.
    Horn D, Hess J, Freier K, Hoffmann J, Freudlsperger C.
    Expert Opin Ther Targets; 2015 Jun 01; 19(6):795-805. PubMed ID: 25652792
    [Abstract] [Full Text] [Related]

  • 28. Knockdown of HPIP Inhibits the Proliferation and Invasion of Head-and-Neck Squamous Cell Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway.
    Chen Y, Zhao R, Zhao Q, Shao Y, Zhang S.
    Oncol Res; 2016 Jun 01; 24(3):153-60. PubMed ID: 27458096
    [Abstract] [Full Text] [Related]

  • 29. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J, Feng L, Tian C, Tang YL, Tang Y, Hu FQ.
    Eur Rev Med Pharmacol Sci; 2018 Dec 01; 22(23):8135-8144. PubMed ID: 30556851
    [Abstract] [Full Text] [Related]

  • 30. Campothecin suppresses cell proliferation and migration in head and neck squamous cell carcinoma by blocking RAB27A-mediated phosphatidylinositol 3 kinase (PI3K)/protein kinase B (AKT) pathway.
    Zhao Y, Wang Y, Zhao L, Qu L, Zheng JH.
    J Physiol Pharmacol; 2024 Apr 01; 75(2):205-213. PubMed ID: 38736267
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Silencing of long non-coding RNA LINC00958 inhibits head and neck squamous cell carcinoma progression and AKT/mTOR signaling pathway by targeting miR-106a-5p.
    Yang YF, Feng L, Shi Q, Wang LW, Hou LZ, Wang R, Fang JG.
    Eur Rev Med Pharmacol Sci; 2020 Aug 01; 24(16):8408-8417. PubMed ID: 32894548
    [Abstract] [Full Text] [Related]

  • 35. Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas.
    Su YC, Lee WC, Wang CC, Yeh SA, Chen WH, Chen PJ.
    Int J Mol Sci; 2022 Dec 12; 23(24):. PubMed ID: 36555391
    [Abstract] [Full Text] [Related]

  • 36. The PI3K/Akt/mTORC signaling axis in head and neck squamous cell carcinoma: Possibilities for therapeutic interventions either as single agents or in combination with conventional therapies.
    Akbari Dilmaghani N, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Bashash D.
    IUBMB Life; 2021 Apr 12; 73(4):618-642. PubMed ID: 33476088
    [Abstract] [Full Text] [Related]

  • 37. AKT3 is a key regulator of head and neck squamous cell carcinoma.
    Takahashi H, Rokudai S, Kawabata-Iwakawa R, Sakakura K, Oyama T, Nishiyama M, Chikamatsu K.
    Cancer Sci; 2021 Jun 12; 112(6):2325-2334. PubMed ID: 33811778
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ, Wang Y, Wang YY.
    J Cell Physiol; 2019 Jun 12; 234(6):9577-9591. PubMed ID: 30480801
    [Abstract] [Full Text] [Related]

  • 40. Long non‑coding RNA fer‑1‑like family member 4 serves as a tumor suppressor in laryngeal squamous cell carcinoma cells via regulating the AKT/ERK signaling pathway.
    Jiao L, Liu S, Liu L, Hao P, Gong Z, Yan Z, Xiang Y.
    Mol Med Rep; 2020 Dec 12; 22(6):5304-5312. PubMed ID: 33174027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.